Dyax’s mission is to discover, develop, and commercialize innovative biopharmaceuticals for unmet medical needs while delivering outstanding value to patients and stockholders.
They utilise a proprietary drug discovery technology called phage display. This technology provides a unique advantage of being able to identify and develop clinical leads to fuel an internal pipeline. They also leverage phage display into licenses and collaborations with companies and researchers interested in furthering their own pipelines.
Dyax Website: http://www.dyax.com